BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260826T130000
DTEND;TZID=America/New_York:20260826T140000
DTSTAMP:20261030T153059
CREATED:20260811T194603Z
LAST-MODIFIED:20260811T194603Z
UID:73448-1787749200-1787752800@hemoalliance.org
SUMMARY:🟥 Member Webinar : New HANS PBM Agreement Opportunities
DESCRIPTION:
URL:https://hemoalliance.org/alliance-events/member-webinar-new-hans-pbm-agreement-opportunities/
CATEGORIES:Members Only,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260923T130000
DTEND;TZID=America/New_York:20260923T140000
DTSTAMP:20261030T153059
CREATED:20260828T162902Z
LAST-MODIFIED:20260831T212519Z
UID:73534-1790168400-1790172000@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar From Novo Nordisk - Preapproval Information Exchange: Denecimig for the treatment of hemophilia A
DESCRIPTION:Date: Wednesday\, September 23rd\, 2026\nTime: 1:00pm – 2:00pm ET \n \n \nWEBINAR TOPIC:\nPreapproval Information Exchange: Denecimig for the treatment of hemophilia A \nOBJECTIVES:\nDenecimig is a novel FVIIIa mimetic agent currently under investigation for the treatment of hemophilia A (congenital FVIII deficiency) with or without FVIII inhibitors. Denecimig has not been approved for any indication by any regulatory authority. This webinar will offer healthcare decision-makers an overview of the burden of disease in patients with hemophilia A\, a detailed introduction to denecimig\, its delivery (dosing and administration)\, and a summary of its clinical trial program. Denecimig is an investigational agent\, and its efficacy and safety have not been established. \n\nAUDIENCE:\nAll HTC Staff \nSPEAKER:\nCraig Schmidt\, PharmD\nMedical Accounts Associate Director\nNovo Nordisk Medical Affairs \nBefore joining Novo Nordisk in 2019\, Craig had been in the Community Pharmacy and Managed Care settings for 13 years and held various roles and leadership positions. Of note\, Craig was the Pharmacy Director of a Regional Health Plan that served over a million Medicaid\, Medicare\, and Commercially insured patients within the New York Metro area. \nCraig currently serves as a Medical Accounts Director for Novo Nordisk\, a global healthcare company with over 100 years of innovation and leadership in diabetes\, obesity\, and rare disease care. Craig is responsible for providing scientific support to payers\, specialty pharmacies\, and other stakeholders that advance the care for patients living with rare diseases. \nCraig earned his Doctor of Pharmacy from St. John’s University\, and is currently based out of Queens\, NY.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-novo-nordisk-preapproval-information-exchange-denecimig-for-the-treatment-of-hemophilia-a/
CATEGORIES:Members Only,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261029T130000
DTEND;TZID=America/New_York:20261029T140000
DTSTAMP:20261030T153059
CREATED:20261001T185521Z
LAST-MODIFIED:20261012T121206Z
UID:73727-1793278800-1793282400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar From Pfizer - HYMPAVZI: Expanded to Adults With Inhibitors and Children Aged 6+
DESCRIPTION:This content is available to members only. Please login or register to view this area.
URL:https://hemoalliance.org/alliance-events/member-webinar-hemophilia-alliance-hosts-a-webinar-from-pfizer-hympavzi-expanded-to-adults-with-inhibitors-and-children-aged-6/
CATEGORIES:Members Only,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261030T140000
DTEND;TZID=America/New_York:20261030T150000
DTSTAMP:20261030T153059
CREATED:20261009T220650Z
LAST-MODIFIED:20261012T121342Z
UID:73823-1793368800-1793372400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar From Genentech - Advancing Hemophilia A Care: From Clinical Evidence to Peer Perspectives
DESCRIPTION:This content is available to members only. Please login or register to view this area.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-genentech-advancing-hemophilia-a-care-from-clinical-evidence-to-peer-perspectives/
CATEGORIES:Members Only,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261112T120000
DTEND;TZID=America/New_York:20261112T130000
DTSTAMP:20261030T153059
CREATED:20261012T180727Z
LAST-MODIFIED:20261020T170728Z
UID:73835-1794484800-1794488400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar from Sanofi - Voices of ALTUVIIIO: Real-World Insights From Two Treatment Journeys
DESCRIPTION:This content is available to members only. Please login or register to view this area.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-sanofi-real-world-insights-from-two-hemophilia-a-treatment-journeys/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR